IPP Bureau
Vestige launches nutritional supplement for women
By IPP Bureau - March 10, 2022
It has blended 36 important ingredients for a woman’s health, which has a mix of natural extracts, amino acids, multivitamins and minerals
Artificial retinal device mimics human optical illusions: WPI-MANA
By IPP Bureau - March 10, 2022
The team built a multiple ionic device system, each of which had a lithium cobalt oxide channel arranged on a common lithium phosphorus oxynitride electrolyte
Metropolis Healthcare announces 2nd edition of Healthcare Heroes awards
By IPP Bureau - March 10, 2022
As a part of its CSR initiatives, the ‘Healthcare Heroes of India’ Awards by Metropolis aims to identify and recognize those individuals and institutions in healthcare sector with a strong sense of purpose and commitment towards patient care and who have prioritized it over all other growth parameters
Lupin Diagnostics opens first Reference Lab in East India
By IPP Bureau - March 10, 2022
It is also setting up laboratories in West Bengal, Assam, Bihar, Jharkhand and Orissa to comprehensively cater to the East India region
Molecular Health and researchers prove new approach to anticipate molecular causation
By IPP Bureau - March 10, 2022
The studies demonstrate a standardized strategy to extend mechanistic modeling and systems pharmacology into drug safety and mode of action assessments that has relevance for drug development and a variety of other contexts
AXA in India boosts telemedicine helpline with free specialist teleconsultation feature
By IPP Bureau - March 10, 2022
SAATH is a ‘One AXA’ public health initiative between AXA France Vie, AXA GO Business Operations, and AXA XL
Zydus Lifesciences subsidiary Sentynl acquires BridgeBio’s Nulibry
By IPP Bureau - March 09, 2022
Nulibry is approved by the U.S. Food and Drug Administration (USFDA) to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening paediatric genetic disorder
Alkido Pharma and Cedars-Sinai enter Master Collaboration Agreement
By IPP Bureau - March 09, 2022
Cedars-Sinai Technology Ventures has had 114 patents issued for the fiscal year 2021 and has 511 active technologies under development, as of July 2021
USFDA approves Evoke Spinal Cord Stimulation System
By IPP Bureau - March 09, 2022
Transformative closed-loop technology senses the spinal cord's response to stimulation and instantaneously adjusts therapy to sustain durable, optimized treatment
OpenEye Scientific and Gaussian collaboration expands quantum chemistry calculations
By IPP Bureau - March 09, 2022
Using Orion, pharmaceutical and biotechnology companies, as well as any industrial researcher who wishes to perform electronic structure calculations, can gain access to elastic and flexible computational resources in the Cloud
Alvotech settles with AbbVie to secure US rights to Humira biosimilar
By IPP Bureau - March 09, 2022
Alvotech expects AVT02 (adalimumab) will be marketed in the U.S., subject to regulatory approval, on July 1, 2023
Dr. Andreas Amrein joins Advanced Clinical to lead expansion in APAC, Europe and Canada
By IPP Bureau - March 09, 2022
With over 20 years of international leadership experience, Dr. Amrein has led many teams and organizations across over 30 geographies
Venus Remedies wins WHO GDP certification
By IPP Bureau - March 09, 2022
Internationally accepted pharmaceutical GDP regulations stipulate that distributors of pharmaceutical products and warehouses must align their operations with the specified standards
WHO Global Centre for Traditional Medicine to come up in Jamnagar
By IPP Bureau - March 09, 2022
It will be the first and only global office for traditional medicine in the world
SRL Diagnostics report indicates women neglect routine tests
By IPP Bureau - March 09, 2022
Routine tests undertaken by women dropped by 35% in 2020
